Fosamax Cost in Alabama 2026: Alendronate Prices, Medicaid Coverage, and Savings Options

What Does Fosamax Actually Cost in Alabama in 2026?

Generic alendronate at Alabama retail pharmacies averages about $15 per month for the 70 mg once-weekly tablet in 2026. Brand-name Fosamax sits considerably higher at a manufacturer list price near $80 per month, though almost no cash-paying patient needs to pay that figure given generic availability. The price spread between brand and generic is wider for alendronate than for most osteoporosis drugs because the patent expired in 2008 and competition among manufacturers has driven the generic price down sharply.

A 4-tablet supply (one month of weekly dosing) at major Alabama chains such as Walmart, CVS, and Walgreens typically costs between $10 and $20 depending on the pharmacy. GoodRx and similar coupon aggregators can push that price toward $9 at specific zip codes in Birmingham, Huntsville, and Mobile. Rural Alabama pharmacies show slightly higher prices, averaging closer to $18 to $22 per month, likely reflecting lower prescription volume and reduced negotiating use with wholesalers.

Alendronate is also available as a 10 mg daily tablet, though the once-weekly 70 mg formulation dominates prescribing because adherence is meaningfully better. The Fracture Intervention Trial (FIT), published in JAMA in 1998 (N=2,027), confirmed that alendronate reduced hip fracture risk by 47% relative to placebo over three years in women with confirmed osteoporosis, establishing the clinical rationale for long-term therapy that drives ongoing demand [1].

Patients who pay cash for the generic almost always save money by using a pharmacy discount card rather than their deductible-phase insurance benefits. Ask the pharmacist to run both the insurance claim and a GoodRx or Cost Plus Drugs price before choosing how to pay.

Does Alabama Medicaid Cover Fosamax or Generic Alendronate?

Alabama Medicaid does not cover alendronate (brand or generic) as of 2026. This is a documented gap in the Alabama Medicaid preferred drug list that affects tens of thousands of Medicaid-enrolled Alabamians who have osteoporosis or osteopenia.

The Alabama Medicaid Agency publishes its preferred drug list through the Alabama Department of Public Health pharmacy program. Bisphosphonates as a class have inconsistent coverage across state Medicaid programs, and Alabama's current formulary excludes alendronate without a covered alternative in the same drug class for most beneficiary categories. Patients who are dually eligible (Medicare and Medicaid) may access alendronate through their Medicare Part D plan instead. Medicare Part D plans generally do cover generic alendronate, often at a $0 to $5 Tier 1 or Tier 2 copay.

For Medicaid-only enrollees, the practical alternatives are:

• Applying for a prior authorization exception (success rates are low for drugs not on the preferred drug list, but not zero)
• Using a 503A compounding pharmacy (discussed below)
• Accessing manufacturer or nonprofit patient-assistance programs

The exclusion is medically consequential. Osteoporosis affects roughly 10 million Americans, and Alabama's older adult population has one of the highest rates of hip fracture-related hospitalization in the Southeast according to CDC data [2]. Leaving alendronate off the Medicaid formulary creates a real barrier for low-income patients who need fracture prevention.

How Commercial Insurance Covers Alendronate in Alabama

Most private insurance plans in Alabama cover generic alendronate, typically at Tier 1 or Tier 2. Tier 1 copays commonly run $0 to $10 per month. Tier 2 copays range from $10 to $45 depending on the plan design.

Blue Cross Blue Shield of Alabama, which holds the largest individual and group market share in the state, lists generic alendronate on its preferred formulary for most plan types. UnitedHealthcare, Aetna, and Humana plans sold on the Alabama ACA marketplace similarly cover the generic. Brand-name Fosamax almost always sits on Tier 3 or Tier 4, where cost-sharing can reach $60 to $100 per month even with insurance, making the generic the rational choice for virtually every insured patient.

Employer-sponsored plans vary. High-deductible health plans (HDHPs) paired with HSAs require patients to pay the full negotiated rate until their deductible is met, which can make even a generic prescription cost $20 to $50 at the pharmacy counter early in the plan year. After the deductible, the Tier 1 or Tier 2 copay applies.

One practical step often overlooked: ask your prescriber to write the prescription as "alendronate 70 mg" (generic name, no brand specified). Some pharmacy software defaults to brand-name Fosamax when a physician writes "Fosamax," which can trigger a higher tier and an unnecessary step of requesting a generic substitution.

Is Compounded Alendronate Legal in Alabama, and What Does It Cost?

Compounded alendronate is legally dispensed in Alabama through state-licensed 503A compounding pharmacies. Federal law under the Drug Quality and Security Act (DQSA) and Alabama State Board of Pharmacy regulations permit 503A pharmacies to prepare patient-specific compounds, including alendronate formulations, when a licensed prescriber provides a valid prescription [3].

503A pharmacies differ from 503B outsourcing facilities. A 503A pharmacy compounds for individual patients based on a prescription; a 503B facility produces sterile bulk compounds for healthcare institutions. Alendronate is an oral solid, so 503A is the applicable category here. Alabama has no state-level prohibition on compounding alendronate, and several pharmacies in the state offer it.

The cost for compounded alendronate through a 503A pharmacy varies by arrangement, but some telehealth and specialty pharmacy programs structure pricing such that the compounded drug costs the patient $0 per month when bundled with a membership or prescriber visit fee. This model has grown in states where Medicaid formulary gaps leave low-income patients without affordable options.

One clinical caveat: compounded alendronate has not been independently tested in large randomized trials the way the branded and generic tablets have. The FIT trial used brand-name Fosamax tablets [1]. Clinicians at HealthRX recommend confirming with any 503A pharmacy that their compounded alendronate uses USP-grade active pharmaceutical ingredient and is prepared under conditions that meet current good compounding practice (CGCP) standards. Ask for a certificate of analysis.

Can You Get a Fosamax Prescription via Telehealth in Alabama?

Yes. Telehealth prescribing of alendronate is legal in Alabama. Alabama was among the states that expanded telehealth prescribing authority during the COVID-19 public health emergency, and subsequent state legislation has preserved those expansions for most non-controlled medications [4].

Alendronate is not a controlled substance. A licensed Alabama prescriber (physician, physician assistant, or certified registered nurse practitioner) can evaluate a patient via audio-video telehealth and, if clinically appropriate, issue a prescription for alendronate. The prescriber must hold an active Alabama license and the patient must be physically located in Alabama at the time of the visit.

HealthRX telehealth visits for bone health assessment typically include a review of recent DXA scan results (T-score at or below -2.5 defines osteoporosis; T-score between -1.0 and -2.5 defines osteopenia), fracture history, calcium and vitamin D intake, and fall-risk factors. The 2022 American Association of Clinical Endocrinology (AACE) Clinical Practice Guideline for the Diagnosis and Treatment of Postmenopausal Osteoporosis states: "Bisphosphonates are recommended as first-line pharmacological therapy for postmenopausal osteoporosis in patients at high fracture risk" [5].

A telehealth visit removes the travel barrier for patients in rural Alabama counties, many of which lack local endocrinologists or bone-health specialists. Jefferson, Madison, and Mobile counties have reasonable specialist density, but patients in Wilcox, Perry, and Sumter counties often face 90-minute drives to reach an endocrinologist. Telehealth changes that math entirely.

What Are the Cheapest Ways to Get Alendronate in Alabama?

The lowest out-of-pocket cost for alendronate in Alabama in 2026 depends on your insurance status. Here is a rank-ordered look at the options.

Option 1: Medicare Part D (dual-eligible or Medicare-only) For patients 65 and older or those on disability Medicare, Part D plans routinely place generic alendronate at Tier 1 with a $0 copay. This is often the cheapest path available.

Option 2: Commercial insurance Tier 1 copay Most BCBS of Alabama and Aetna plans cover the generic at $0 to $10 per month after the plan year deductible is met.

Option 3: Mark Cuban Cost Plus Drugs Cost Plus Drugs (costplusdrugs.com) lists generic alendronate 70 mg (4 tablets) for around $6 to $8 plus a $5 shipping fee. This beats most retail cash prices in Alabama and requires no coupon negotiation.

Option 4: GoodRx or RxSaver coupon at a local pharmacy GoodRx prices at Alabama pharmacies range from $9 to $18 per month depending on pharmacy and zip code. These coupons cannot be combined with insurance.

Option 5: 503A compounding pharmacy with telehealth bundle For patients whose insurance does not cover alendronate and who do not qualify for Medicare, a telehealth provider offering compounded alendronate at $0 drug cost (visit fee applies) may be the most affordable total-cost option.

Option 6: Merck patient-assistance program Merck offers the Merck Patient Assistance Program (MPAP) for brand-name Fosamax for patients who meet income criteria (generally at or below 200% of the federal poverty level). Applications are submitted through Merck Helps at 1-800-727-5400. Given that generic alendronate is under $20 per month for most patients, this program is most relevant for patients who specifically require the brand.

The table below (to be inserted by the editorial team as a custom figure) will display these six options side by side with estimated monthly costs for a representative Alabama patient in 2026 across three insurance scenarios: uninsured, Medicaid-only, and Medicare Part D.

How Does Alendronate Work and Why Does Dosing Matter for Cost?

Alendronate is a nitrogen-containing bisphosphonate. It binds to hydroxyapatite crystals in bone and inhibits osteoclast-mediated bone resorption, shifting the bone remodeling cycle toward net bone formation [6]. This mechanism underlies both its efficacy and its narrow therapeutic profile.

Dosing affects cost in a direct way. The 70 mg once-weekly tablet and the 10 mg once-daily tablet are therapeutically equivalent, but the weekly formulation costs less per month because it requires fewer tablets (4 vs. 30) and carries better adherence data. One meta-analysis of 11 observational studies found that patients on weekly bisphosphonate dosing had 15 to 20 percentage-point higher one-year persistence rates compared with daily dosing [7]. Stopping alendronate before 36 months substantially reduces fracture protection, so adherence is not a minor concern.

The 70 mg oral solution exists for patients who cannot swallow tablets, but this formulation is rarely stocked at Alabama retail pharmacies and may need to be special-ordered, adding 3 to 7 days to the first fill and sometimes a modest surcharge.

Administration requirements matter for efficacy. Patients must take alendronate with 6 to 8 ounces of plain water, remain upright for at least 30 minutes, and avoid food, drink (other than water), and other medications for that 30-minute window. Esophageal irritation and atypical femoral fracture (with very long-term use exceeding 5 to 10 years) are the primary safety considerations discussed in the FDA prescribing information [8].

How Long Should Patients Stay on Alendronate?

Most guidelines recommend reassessing alendronate therapy at 3 to 5 years. The FDA-reviewed data support continued therapy for up to 10 years in high-risk patients, but a "drug holiday" is often considered for lower-risk patients after 5 years.

The FLEX (Fracture Intervention Trial Long-Term Extension) trial enrolled 1,099 women who had already completed 5 years of alendronate therapy and randomized them to 5 more years of alendronate versus placebo. Women who continued alendronate had a lower risk of clinical vertebral fractures (2.4% vs. 5.3%, P<0.001) but no significant difference in hip fracture rates compared with those who stopped [9]. This finding supports individualized decisions: a patient with a T-score well above -2.5 after 5 years and no prevalent vertebral fractures is a reasonable candidate for a drug holiday, while a patient with a T-score at -3.0 or lower should generally continue.

From a cost perspective in Alabama, extending therapy by 5 additional years at the $15 per month generic price adds $900 in total drug cost, a number that should be weighed against the direct medical cost of a hip fracture, which averages $36,000 to $55 to 000 in hospitalization and rehabilitation charges according to Agency for Healthcare Research and Quality data [10].

Alendronate vs. Other Osteoporosis Drugs: Cost Context in Alabama

Alendronate is the least expensive prescription osteoporosis medication available in Alabama. Knowing the alternatives helps patients and prescribers make cost-informed decisions.

Risedronate (Actonel), another oral bisphosphonate, costs approximately $25 to $40 per month as a generic in Alabama. Ibandronate (Boniva), dosed monthly, runs $30 to $60 per month generic. Both are more expensive than alendronate without meaningful efficacy advantages for most patients.

Denosumab (Prolia), a RANK-L inhibitor given as a 60 mg subcutaneous injection every 6 months, lists at roughly $1,300 per injection before insurance. For Alabama patients with commercial insurance or Medicare Part B, denosumab may be covered at low cost-sharing, but it is not affordable as a cash-pay drug.

Romosozumab (Evenity) and teriparatide (Forteo) are anabolic agents reserved for very high-risk patients; both exceed $1,500 per month at list price and are rarely relevant to a cost comparison with generic alendronate.

The Endocrine Society's 2019 Clinical Practice Guideline on pharmacological management of osteoporosis in postmenopausal women states: "We recommend oral bisphosphonates (alendronate, risedronate, ibandronate) as first-line treatment due to their established efficacy and favorable cost profile" [11].

For most Alabama patients at standard fracture risk, alendronate remains the clinically appropriate and economically sensible first choice.

Specific Steps to Pay as Little as Possible for Alendronate in Alabama

Patients who want the lowest possible price should take these concrete steps in order.

First, confirm the prescription is written for "alendronate 70 mg tablet" (generic name) not "Fosamax."

Second, before leaving the prescriber's office or ending a telehealth visit, ask whether the prescriber has sample 70 mg tablets. Samples are rare for a generic this inexpensive, but some practices that see high bisphosphonate volume keep them for patients starting therapy who want to assess tolerability before committing to a month's supply.

Third, check Cost Plus Drugs online before going to any retail pharmacy. If the $6 to $8 price plus $5 shipping beats your local cash price, order there.

Fourth, if using a retail pharmacy, ask the pharmacist to compare your insurance claim price against a GoodRx coupon price for that specific pharmacy. The lower of the two is usually the right choice, and pharmacists are required by most state board rules to inform patients of the cheaper option if asked.

Fifth, if you are uninsured or on Alabama Medicaid (which does not cover alendronate), contact a HealthRX telehealth provider to discuss whether 503A compounded alendronate at a reduced or zero drug cost fits your clinical situation.

Sixth, if you are 65 or older and not yet enrolled in Medicare Part D, a licensed insurance broker can review Part D plan options during the annual enrollment period (October 15 to December 7). A plan with $0 Tier 1 alendronate coverage can save a patient $180 per year compared with paying cash.